Context Therapeutics Inc (CNTX) — Strategic Asset Allocation Index
Context Therapeutics Inc (CNTX) has a Strategic Asset Allocation Index of 0.1% as of June 2023. Strategic assets (PP&E of $28.70K plus long-term investments of $-) total $28.70K, measured against net assets of $24.00 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Context Therapeutics Inc Strategic Asset Allocation Index (2016–2017)
This chart shows how Context Therapeutics Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2016 to 2017. As of June 2023, the index stands at 0.1%, representing strategic assets of $28.70K against net assets of $24.00 Million USD. Explore Context Therapeutics Inc operating cash flow efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Context Therapeutics Inc (2016–2017)
The table below presents the year-by-year Strategic Asset Allocation Index for Context Therapeutics Inc from 2016 to 2017, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Context Therapeutics Inc (CNTX) total market value.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2017 | 0.0% | $29.00K | $29.00K | $- | $58.95 Million | ▼ -0.4 pp |
| 2016 | 0.5% | $60.00K | $60.00K | $- | $13.12 Million | — |